• 20
    0

    In January earlier this year, I wrote an article on Bausch Health Companies (BHC, Financial), in which I speculated that the upcoming spin-off of the Bausch + Lomb eye care business and its aesthetic business (named Solta) would unlock tremendous value. After publishing that article, I invested in the stock. Bausch was to split into ...